Provided By GlobeNewswire
Last update: Sep 5, 2024
NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s disease, today announced that Lexeo management will participate in corporate presentations and fireside chats at the following investor conferences:
NASDAQ:LXEO (7/22/2025, 2:06:42 PM)
3.89
-0.07 (-1.77%)
Find more stocks in the Stock Screener